1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
A Delaware Court of Chancery approved on June 30, 2026 a settlement of the Dollens shareholder lawsuit, and on July 8, 2026 Goosehead and its pre-IPO stockholders signed an Amended and Restated Stockholders Agreement. While those holders own at least 10% of common shares, they must approve certain major corporate actions and may nominate a majority of the board, including the Chairman, which gives them more influence over governance than other common stockholders have.
On June 30, 2026, the Court of Chancery of the State of Delaware approved the settlement of the Dollens Action (C.A. No. 2022-1018-JTL).
The A&R Stockholders Agreement, dated July 8, 2026, applies while pre-IPO holders beneficially own at least 10% of outstanding common stock.
Pre-IPO holders must approve mergers or sales of substantially all assets, asset deals above 15% of total assets, equity issuances above $50 million, charter amendments, and changes to board size.
Pre-IPO holders may nominate a majority of the board, including the Chairman, but the board need not endorse those nominees if its fiduciary duties require otherwise.
IGC Pharma furnished an updated investor presentation dated July 2026 under Regulation FD, filed as Exhibit 99.1 to a Form 8-K dated July 13, 2026. The presentation covers the Phase 2 CALMA trial of IGC-AD1 for agitation in Alzheimer's dementia, which the filing describes as investigational and not approved by the FDA, and it presents illustrative valuation scenarios that the company says are hypothetical and not forecasts.
The CALMA Phase 2 trial has a target of 146 participants, and the presentation says more than 80% have completed dosing.
The presentation cites a current valuation of about $30 million as of July 10, 2026, with illustrative post-Phase 2 scenarios of $350 million to $750 million over 4 to 9 months.
Blinded pooled data show a mean change in CMAI of −13.6 at week 2 and −14.9 at week 6, which the company says cannot establish treatment effect or efficacy.
On July 13, 2026, Tavia Acquisition Corp. and Vita Inclinata Technologies signed a non-binding letter of intent for a business combination that would make Vita a publicly traded company through a de-SPAC transaction. The proposed transaction values Vita at a pre-money enterprise value of $450 million, assuming Vita completes a pending strategic acquisition in the defense and industrials market. The companies state that a definitive agreement is expected within 30 days, but the filing says no assurance can be given that a deal will be signed or completed on the contemplated terms.
Non-binding LOI sets a pre-money enterprise value of $450 million for Vita, assuming Vita completes a pending defense and industrials acquisition
Definitive agreement expected within the next thirty days; closing anticipated in the fourth quarter of 2026
Parties agreed to a 45-day exclusivity period for due diligence and negotiation of a Business Combination Agreement
Filing states no assurance that a definitive agreement will be reached or that the deal will close on the terms or timeframe contemplated
CoStar Group appointed Robin Rossmann, its Managing Director, Europe, as Chief Financial Officer effective July 31, 2026. He succeeds Christian Lown, who resigned to pursue an opportunity outside the company's industry, and the company says the resignation was not due to any disagreement on operations, policies or practices. The filing also details Rossmann's pay package, including a $2.5 million equity grant and a $500,000 relocation subsidy.
Robin Rossmann appointed CFO effective July 31, 2026, reporting to Founder and CEO Andy Florance
Christian Lown resigned as CFO effective July 31, 2026; he notified the company on July 7, 2026
Rossmann's base salary is £440,000, rising to $590,000 after relocation to Arlington, VA, with a target bonus of 100% of base salary
One-time equity grant valued at $2.5 million as of July 31, 2026, plus a $500,000 relocation subsidy
Oil States International amended the executive agreement of President and CEO Lloyd A. Hajdik, effective July 9, 2026, restructuring how severance is calculated on certain qualifying termination events. The filing sets out a larger lump sum severance if he is terminated without Cause or resigns for Good Reason within 24 months after a Change of Control, and a smaller lump sum for a no-Cause termination outside that window.
Amendment dated July 9, 2026 to the Executive Agreement originally effective December 9, 2013.
Within 24 months after a Change of Control, a qualifying termination pays a lump sum of 3.0 times Termination Base Salary plus Target AICP.
Outside that 24-month window, a termination without Cause pays a lump sum of 1.5 times Termination Base Salary plus Target AICP.
The filing states all other terms of the Executive Agreement remain in effect; the amendment is filed as Exhibit 10.1.
Brown-Forman said President and CEO Lawson Whiting will retire, effective when a successor is appointed, after nearly 30 years with the company. The board has begun a search for a new CEO, and the company reiterated its fiscal 2027 outlook, first disclosed on June 4, 2026, which means the announcement did not change financial guidance. Leadership transitions can add uncertainty, so shareholders will be watching who is chosen and how the company's strategy continues under new leadership.
Lawson Whiting will retire as President and CEO after nearly 30 years, effective upon the appointment of his successor.
The Corporate Governance and Nominating Committee, chaired by Tracy Skeans, will lead the search, which will consider internal and external candidates.
Whiting will remain available in an advisory capacity for a period after a successor is appointed.
Brown-Forman reiterated its fiscal 2027 outlook, as disclosed on June 4, 2026.
NXG Cushing Midstream Energy Fund entered into a distribution agreement on July 10, 2026, allowing it to sell up to 1,500,000 new common shares through Foreside Fund Services over time at market prices. Shares may not be sold below net asset value per share plus the commission, and UBS Securities LLC is a sub-placement agent. New shares would dilute existing holders, but the filing does not say how many shares have been sold so far.
Up to 1,500,000 common shares may be offered under the distribution agreement dated July 10, 2026
Minimum sale price is net asset value per share plus the commission paid to the distributor
UBS Securities LLC is a sub-placement agent under an agreement also dated July 10, 2026
The offering began July 10, 2026 under a shelf registration statement; Skadden, Arps legal opinion filed as Exhibit 5.1
Energy Recovery (ERII) appointed John Mitchell to its Board of Directors effective July 9, 2026, bringing the board to six directors. Mitchell previously served as Senior Vice President and General Manager of the Sensor Solutions business at TE Connectivity, a board addition that adds finance and operations experience rather than a change in company performance.
Board appointment dated July 9, 2026; announced in a press release on July 13, 2026
Board size increases to six directors with Mitchell's appointment
Mitchell has more than three decades of finance, operations and technology leadership, including roles at TE Connectivity and Tyco Electronics
Mitchell will receive the same pro-rated compensation and indemnification as the other non-employee directors
Intapp, Inc. entered a five-year, $150.0 million senior secured revolving credit facility with UBS AG, Stamford Branch as administrative agent, dated July 7, 2026, and terminated its prior credit agreement with JPMorgan Chase Bank, N.A. at the same time. No amounts were outstanding under the new facility at closing, and the filing does not describe any change in the company's operations or results.
Five-year senior secured revolving credit facility of $150.0 million, with a $10.0 million letter of credit subfacility
Borrowings bear interest at Term SOFR plus 1.50% to 2.25%, or an alternate base rate plus 0.50% to 1.25%, based on total net leverage ratio
Facility is secured by substantially all assets (excluding real estate interests) of the company and subsidiary guarantors, and includes a maximum consolidated total net leverage ratio covenant
Prior credit agreement dated October 5, 2021 with JPMorgan Chase Bank, N.A. was terminated concurrently
Effective July 9, 2026, Pliant Therapeutics increased its board from seven to nine members and appointed Robert Iannone, M.D., M.S.C.E., and Flavia Borellini, Ph.D., as directors. Borellini will chair the R&D Committee, and Iannone will join it. The filing describes director pay and stock options but does not report any financial results or changes to company operations.
Board size increased from seven to nine members, effective July 9, 2026.
Robert Iannone, M.D., M.S.C.E., appointed as a Class I director; Flavia Borellini, Ph.D., appointed as a Class II director.
Borellini named chairperson of the R&D Committee; Iannone named a member.
Each new director receives a $40,000 annual retainer and an option for 60,000 shares vesting over three years. Iannone receives an extra $7,500 retainer and Borellini an extra $15,000 for committee roles.
American Shared Hospital Services said its Chief Financial Officer, Raymond S. Frech, resigned effective July 7, 2026, for personal reasons, and that the resignation was not related to any disagreement on accounting policies or practices. The Board named Chief Accounting Officer Alexis N. Tirrito as interim CFO and principal financial and accounting officer, effective immediately, while she keeps her CAO and Secretary roles.
Raymond S. Frech resigned as CFO effective July 7, 2026, for personal reasons; the filing says a severance agreement with customary releases was entered into
Alexis N. Tirrito, CAO and Secretary since October 2021, was appointed interim CFO on July 7, 2026
Tirrito's base salary was set at $240,000, effective July 7, 2026, with a 2026 target bonus of 20% of base salary
ONE Gas expanded its board from eight to nine members on July 13, 2026, appointing Nickolas Stavropoulos, a retired chief operating officer of Pacific Gas & Electric and National Grid, to fill the new seat. The appointment adds an energy industry veteran with more than 40 years of experience to the board, and his director pay is set at a prorated $105,000 retainer plus $140,000 in stock.
Board expanded from eight to nine members; Stavropoulos, 68, appointed effective July 13, 2026
Serves on the Audit, Corporate Governance and Executive Compensation Committees
Annual retainer of $105,000 plus stock retainer valued at $140,000, both prorated through May 19, 2027
Stavropoulos was PG&E chief operating officer from March 2017 to September 2018
On July 10, 2026, Realty Income entered a Fifth Amended and Restated Credit Agreement that raises its unsecured multicurrency revolving credit capacity to $5.5 billion from $4.0 billion, and adds UK and Netherlands subsidiaries as joint borrowers. The company also doubled the maximum outstanding amounts under its U.S. and euro commercial paper programs to $2.75 billion each from $1.50 billion each. The filing says the larger capacity and lower borrowing costs add financial flexibility for shareholders, though the company will carry more borrowing capacity.
Revolving credit capacity rises to $5.5 billion from $4.0 billion, with an accordion feature that can increase it to $6.5 billion subject to lender commitments.
Two $2.75 billion tranches initially mature on April 29, 2029 and July 10, 2030, each with two six-month extension options.
Maximum outstanding commercial paper is $2.75 billion under each of the U.S. and euro programs, up from $1.50 billion each.
The press release cites all-in drawn pricing of 80 basis points over SOFR, a reduction of 5.0 basis points from the prior facilities.
RMG ML Sports Holdings, a special purpose acquisition company, said holders of units from its June 11, 2026 IPO may separately trade ordinary shares and rights starting on or about July 17, 2026. The filing is administrative: it changes how the securities trade, but it reports no financial results, deal terms, or change in the company's business.
Separate trading of ordinary shares (SHOT) and rights (SHOTR) starts on or about July 17, 2026.
Units not separated continue to trade under SHOTU on The Nasdaq Global Market.
Each unit holds one ordinary share and one right to receive one-eighth of an ordinary share upon an initial business combination.
Holders must have brokers contact transfer agent Continental Stock Transfer & Trust Company to separate units.
Welltower OP LLC issued C$750 million of 3.850% notes due 2031 and C$400 million of 4.150% notes due 2033 on July 13, 2026, guaranteed by parent Welltower Inc. The company says it will use the proceeds for general corporate purposes, including debt repayment and funding its healthcare and seniors housing investment pipeline.
2031 Notes: C$750 million at 3.850%, maturing August 15, 2031
2033 Notes: C$400 million at 4.150%, maturing August 15, 2033
Interest is paid semiannually from February 15, 2027, and the notes are senior unsecured, guaranteed by Welltower Inc.
Notes were sold under an underwriting agreement dated July 6, 2026, with RBC, Scotia, TD and BMO as representatives
Ceva, Inc. disclosed that Executive Vice President and Chief Operating Officer Michael Boukaya agreed with the company to resign, with his last day as COO set for August 1, 2026. He will stay on as an employee through December 31, 2026 to support a smooth transition.
Resignation agreed mutually between Ceva and Michael Boukaya on July 8, 2026
Last day as Chief Operating Officer is August 1, 2026
Boukaya remains an employee through December 31, 2026 to facilitate the transition
Diamondback Energy disclosed selected second-quarter 2026 operating data: average unhedged oil price of $96.82 per barrel and average hedged oil price of $94.33 per barrel, with natural gas prices negative on both measures. The filing also anticipates a $113 million net cash gain and a $64 million net non-cash loss on derivative instruments, which affect the company's realized results. The filing does not include total revenue, net income, earnings per share or guidance.
Oil: $96.82 per barrel unhedged and $94.33 per barrel hedged in Q2 2026
Natural gas: $(2.15) per Mcf unhedged and $(0.34) per Mcf hedged; NGLs $18.56 per barrel
Anticipated net cash gain on derivative settlements of $113 million and net non-cash loss of $64 million
Basic and diluted weighted average shares outstanding of 281,202 thousand for Q2 2026
Inno Holdings disclosed that a Magistrate Judge in the U.S. District Court for the Southern District of Texas issued a Memorandum and Recommendation on July 10, 2026 stating that "there is no TRO in place." The temporary restraining order entered June 25, 2026 against the company is therefore described as no longer in place. The filing contains no financial figures, so its direct financial effect on shareholders is not stated.
Temporary restraining order entered by the Southern District of Texas on June 25, 2026
Magistrate Judge issued a Memorandum and Recommendation on July 10, 2026 stating there is no TRO in place
Filing signed by CEO Ding Wei on July 13, 2026 and includes only Exhibit 104 (cover page XBRL data)
Tactile Systems Technology (Tactile Medical) entered an exclusive U.S. distribution agreement with ElastiMed for the MyoSleeve wearable compression device, covering Department of Veterans Affairs and Department of Defense patients. The company paid an upfront $3 million and committed to certain minimum purchase obligations and marketing support, and the filing gives no revenue or financial outlook for the deal.
Exclusive U.S. distribution rights for MyoSleeve within the VA and DoD systems, announced July 13, 2026
Upfront payment of $3 million to ElastiMed, plus undisclosed minimum purchase and marketing commitments
MyoSleeve has FDA 510(k) clearance for chronic swelling, including chronic edema, lymphedema and venous insufficiency
Klaviyo appointed Erica Smith, former CFO of CyberArk, as its Chief Financial Officer, effective September 1, 2026, replacing Amanda Whalen. Whalen will remain employed until September 4, 2026, then serve in an advisory role through November 16, 2026 to support the transition. The filing describes a CFO change at a company whose financial leadership is shifting, with compensation tied to both time and stock price targets.
Base salary of $550,000 and a target annual cash bonus of 50% of base salary
Time-based RSUs with an initial equity value of $15 million, vesting in 16 quarterly installments
Performance stock units with an initial equity value of $3 million, tied to stock price targets of $30, $50 and $75 per share through February 15, 2029
Amanda Whalen's employment ends September 4, 2026; advisory role runs through November 16, 2026
SouthState Bank Corporation disclosed that James W. Roquemore, a member of its Board of Directors, died on July 9, 2026, after a long illness. The filing describes him as a long-time Board member who served from 1994 to 2020 and again from 2022 to the present, and it does not name a successor or any change to the Board's composition.
James W. Roquemore, a Board member, passed away on July 9, 2026, after a long illness.
He served on the Board from 1994 to 2020 and again from 2022 until his death.
The filing does not name a replacement director or state any change to Board committees.
Shift4 Payments disclosed that on July 8, 2026, a subsidiary entered into Amendment No. 4 to its first lien credit agreement, adding a $1.0 billion incremental senior secured term loan and extending the revolving credit facility maturity to July 8, 2031. As of July 8, 2026, outstanding term loan borrowings totaled $1,995,006,250 and revolving borrowings were $0, so the change increases the company's secured debt load while pushing out revolver maturity.
Incremental $1.0 billion senior secured term loan, fungible with existing Amendment No. 3 Refinancing Term Loans
Revolving credit facility maturity extended to July 8, 2031
Outstanding term loan borrowings of $1,995,006,250 and no revolving loans outstanding as of July 8, 2026
Proceeds to pay transaction fees and costs and for general corporate purposes
OmniAb, Inc. appointed Amechi Nwachuku as Chief Operating Officer effective July 13, 2026. The filing sets his $445,000 base salary, a 45% target bonus and 800,000 stock options, and describes severance terms, including enhanced change-in-control benefits, which matter to shareholders as they define the compensation cost and potential payouts tied to the new role.
Base salary of $445,000 with an annual target bonus equal to 45% of base salary, prorated for 2026
Stock options to purchase 800,000 common shares granted effective August 1, 2026, vesting over four years
Change-in-control agreement provides severance of one times base salary plus one times maximum target bonus, if terminated without cause or resigning for good reason within 24 months of a change in control
N-able said its Chief Revenue Officer, Frank Colletti, left the role effective July 9, 2026, and that Russell Rosa joined as Chief Revenue Officer effective immediately. Rosa will oversee the global sales organization, channel and partner ecosystem, support, and sales operations. The filing does not state any financial results or guidance changes.
Frank Colletti left his position as Chief Revenue Officer effective July 9, 2026.
Colletti may be entitled to severance under his existing employment agreement; any material changes will be disclosed in an amendment.
Russell Rosa joined as Chief Revenue Officer effective immediately, announced July 13, 2026.
Rosa's responsibilities include functions previously overseen by Colletti.
Amphastar Pharmaceuticals increased its board from 10 to 11 seats on July 9, 2026, and appointed Anthony Pierce as a Class III director, effective immediately. The board deemed him independent under Nasdaq listing standards, and he has no committee assignments at this time.
Board size increased from 10 to 11 directors; Pierce appointed effective immediately
Pierce's term runs until the 2028 annual meeting of stockholders
Annual cash retainer of $55,000, pro-rated for his start date
Initial equity grant with aggregate grant date fair value of $300,000, split 50% restricted stock units and 50% stock options, vesting on the first anniversary
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.